2017
DOI: 10.1016/j.jad.2017.05.052
|View full text |Cite
|
Sign up to set email alerts
|

Effect of memantine on C-reactive protein and lipid profiles in bipolar disorder

Abstract: BD patients with high initial CRP levels receiving memantine adjunct treatment have a reduced risk of inflammation and metabolic imbalance. Prospective studies are needed to confirm the long-term outcome for memantine adjunct therapy in BD patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(6 citation statements)
references
References 52 publications
0
6
0
Order By: Relevance
“…CRP is a blood marker of inflammatory states. This molecule is synthetized by the liver in response to signal factors released by macrophages and fat cells, upon stimulation by the cytokines IL-1β, IL-6 and TNF-α during acute-phase inflammatory response, and elevate levels of this protein have been observed in BP patients [8]. For this reason, we believe to have found an important association between CRP and IR levels.…”
Section: Discussionmentioning
confidence: 69%
See 1 more Smart Citation
“…CRP is a blood marker of inflammatory states. This molecule is synthetized by the liver in response to signal factors released by macrophages and fat cells, upon stimulation by the cytokines IL-1β, IL-6 and TNF-α during acute-phase inflammatory response, and elevate levels of this protein have been observed in BP patients [8]. For this reason, we believe to have found an important association between CRP and IR levels.…”
Section: Discussionmentioning
confidence: 69%
“…In fact, some psychiatric diseases, including bipolar disorder have been associated with chronic neuroinflammation status with increase of proinflammatory cytokines levels in blood peripheral circulation [8,9]. Li seems to present anti-inflammatory effect by inhibition of GSK-3…”
Section: David Publishingmentioning
confidence: 99%
“…Furthermore, since immune dysfunction, such as elevated plasma CRP levels, has been strongly implicated in the pathophysiology of BD, targeting the immune system is a strategy for the treatment of bipolar disorder. 59 , 60 As such, numerous clinical trials have investigated the effects of anti-inflammatory agents in the treatment of BD. 60 - 62 Adjunctive anti-inflammatory agents have demonstrated antidepressant effects with N-acetylcysteine (NAC), pioglitazone, minocycline, and nonsteroidal anti-inflammatory drugs in the acute phase of bipolar depression.…”
Section: Discussionmentioning
confidence: 99%
“… 62 Moreover, regardless of illness phase, previous studies also suggested that anti-inflammatory agents are likely most beneficial in patients with mood disorder when subgrouped by immune dysregulation or by childhood maltreatment. 59 , 71 Since low-dose memantine serves as an anti-inflammatory agent through the BDNF signaling pathway, 74 , 75 BD patients with high initial plasma CRP levels receiving memantine adjunct treatment have a reduced risk of inflammation and metabolic imbalance. 59 Additionally, a report showed that the plasma CRP level could predict the differential responses to antidepressants, 76 and clinical trials of tumor necrosis factor antagonists and omega-3 fatty acids demonstrated the role of the initial plasma CRP level in predicting individual treatment responses in patients with major depressive disorder.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation